Author Question: The patient is scheduled to begin treatment with the disease-modifying antirheumatic drug ... (Read 59 times)

jjjetplane · **on:** Jul 23, 2018

The patient is scheduled to begin treatment with the disease-modifying antirheumatic drug methotrexate. In order to avoid a life-threatening adverse effect of the drug, the patient should receive a frequent assessment of:

a. Heart rate
b. Breath sounds
c. Bowel sounds
d. Mental status

Question 2

Which of the following patients would be least likely to be prescribed aspirin therapy?

a. A 12-year-old with a high fever
b. A 37-year-old with vitamin K deficiency
c. A 62-year-old with impaired renal function
d. A 45-year-old with unstable angina

abctaiwan · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: B
Pulmonary fibrosis is an adverse effect of methotrexate and can be life threatening.

Answer to Question 2

ANS: A
Children and adolescents who have influenza or chicken pox should abstain from use of salicy-lates because of the epidemiologic relationship between aspirin use in children and adolescents and Reye's syndrome.